How long does it take for nattokinase to clean your arteries?

Nattokinase supplementation activates your body's natural clot-dissolving system, but the timeline for cardiovascular benefits depends on the specific outcome you're targeting — ranging from immediate fibrinolytic activity to measurable arterial changes over weeks or months of consistent use.

Key Takeaways

Table of Contents

1. What Nattokinase Actually Does (Not a Drain Cleaner)
2. Immediate Fibrinolytic Activity: Hours
3. Early Cardiovascular Effects: 2–4 Weeks
4. Measurable Blood Pressure Benefits: 8 Weeks
5. Arterial Plaque Reduction: 12 Months
6. Why Consistent Daily Dosing Is Critical
7. How to Use Nattokinase Effectively
8. BioAbsorb Nattokinase: Dose, Formulation, and Timing
9. Frequently Asked Questions
10. Conclusion

What Nattokinase Actually Does (Not a Drain Cleaner)

The phrase "cleaning your arteries" can be misleading. Nattokinase doesn't work like a chemical drain cleaner, scrubbing plaque away. Instead, it supports your body's natural fibrinolysis process — the same biological mechanism that dissolves blood clots after an injury heals.

Fibrin is the protein scaffold that gives clots their structure. In excess, fibrin accumulates in blood vessels and contributes to arterial plaque stability and thickness. Nattokinase directly cleaves cross-linked fibrin and activates the production of tissue-type plasminogen activator (tPA), transforming inactive plasminogen into active plasmin, which is your body's primary clot-dissolving enzyme.

Nattokinase also cleaves and inactivates PAI-1, the primary inhibitor of tPA. By reducing PAI-1, nattokinase amplifies your body's endogenous fibrinolytic capacity. This dual mechanism — direct fibrin degradation plus plasmin system activation — is what makes nattokinase distinct from pharmaceutical anticoagulants.

The cardiovascular benefit comes from reduced fibrin accumulation, improved blood flow, and a lower propensity for abnormal clotting. Over time, these changes correlate with measurable improvements in blood pressure, arterial stiffness, and plaque composition.

Immediate Fibrinolytic Activity: Hours

Within hours of oral ingestion, nattokinase reaches the small intestine and is absorbed intact into the bloodstream. Research published in Scientific Reports found that oral administration of nattokinase was associated with fibrinolytic activity in human subjects, suggesting the enzyme retains activity after digestion [4].

Markers including D-dimer and Factor VIII showed sustained changes consistent with enhanced fibrinolysis, with this activity persisting between doses when taken daily. Fibrinolytic activity peaks in the bloodstream within a few hours of taking it, and measurable effects on clotting markers can persist for 8 to 12 hours [4].

This acute fibrinolytic boost is why nattokinase is sometimes taken before long flights or during periods of prolonged immobility — the enzyme supports your natural clot-dissolution system precisely when clotting risk is elevated.

However, this immediate activity does not translate to acute blood pressure changes or rapid plaque reduction. Those effects require weeks to months of consistent use.

Early Cardiovascular Effects: 2–4 Weeks

The first measurable cardiovascular changes appear roughly 2–4 weeks into consistent nattokinase supplementation. In one trial, average diastolic blood pressure dropped noticeably by week four in the nattokinase group, suggesting that the enzyme's cumulative effects on blood vessel function are beginning to manifest.

At this stage, the changes are often modest — blood pressure may decline by 1–2 mmHg, and subjective improvements (better energy, reduced bloating) may be reported. These early signs indicate that nattokinase is beginning to influence blood rheology (how blood flows) and endothelial function (how arteries behave).

However, 2–4 weeks is not yet sufficient for most people to assess true efficacy. The research is clear: full effects require longer.

Measurable Blood Pressure Benefits: 8 Weeks

Eight weeks of consistent nattokinase supplementation is the timeframe supported by the most robust clinical evidence for cardiovascular benefits.

In a double-blind, randomized clinical trial, subjects with prehypertension or stage 1 hypertension who took 2,000 FU of nattokinase daily for 8 weeks showed decreases in systolic and diastolic blood pressure at 8 weeks, but not at 4 weeks. A meta-analysis of six randomized controlled trials with 546 participants found that nattokinase reduced systolic blood pressure by approximately 5.27 mmHg and diastolic by 2.32 mmHg compared to placebo [1].

While these reductions may seem modest, they are clinically meaningful. A 5–6 mmHg systolic reduction corresponds to an estimated 10% reduction in cardiovascular event risk in the general population [1].

A 26-week study found that nattokinase supplementation significantly lowered blood pressure and improved cardiovascular health markers over an extended period, with consistency across trial lengths suggesting nattokinase produces durable benefits rather than effects that fade with time.

At 8 weeks, nattokinase's effect on blood viscosity and microcirculation also becomes measurable. Blood flows more easily through capillaries, oxygen delivery improves, and arterial stiffness may begin to decline.

Arterial Plaque Reduction: 12 Months

This is where the "arterial cleaning" claim becomes most scientifically grounded. Long-term nattokinase use correlates with measurable reductions in arterial plaque burden — but this benefit requires sustained supplementation and higher doses.

A clinical study involving 1,062 participants who took 10,800 FU of nattokinase daily found that after 12 months, there was a significant reduction in the thickness of the carotid artery intima-media (a key marker of atherosclerosis) and in the size of carotid plaque. In that study, high-dose nattokinase supplementation was associated with reducing artery plaque size by 36% in older adults over the course of a year [3].

The mechanism: nattokinase reduces the fibrin scaffold within plaques, making them structurally unstable. Simultaneously, improved blood lipids (particularly LDL-C reduction) and reduced inflammation limit new plaque formation. The net effect is a measurable shrinking of existing atherosclerotic burden.

Large-scale clinical trials have confirmed that nattokinase significantly improves the lipid profile and reduces atherosclerotic plaque area and intima-media thickness with a favorable safety profile [3].

It's important to note: this is not overnight plaque reversal. It requires 12 months of consistent, high-dose supplementation (10,800 FU daily, roughly 5–6 times the standard consumer dose in many formulations). The effect is real, durable, and clinically significant — but it is a slow, cumulative process [3].

Why Consistent Daily Dosing Is Critical

The research shows a clear pattern: nattokinase's cardiovascular benefits are cumulative and dose-dependent. Missing doses, inconsistent timing, or low potency undermines the effect.

No evidence supports sudden or acute blood pressure changes from initial doses; single-dose pharmacokinetic studies confirm no resting blood pressure alteration shortly after ingestion in normotensive subjects. The enzyme works gradually, building on itself day after day [4].

Most people using nattokinase for blood pressure should allow at least 8 weeks of consistent daily use before assessing effectiveness, and blood pressure monitoring with a home device during this period helps track individual response.

Dosage matters too. The large plaque-reduction study used 10,800 FU daily — three times the typical supplemental dose — and observed improvement in nearly 70–95% of participants over 12 months [3]. Lower doses (e.g., 2,000 FU daily) are supported by evidence for modest blood pressure and fibrinolytic benefits but are unlikely to produce the same magnitude of plaque regression.

In that same study, nattokinase was found to be ineffective in lowering lipids and suppressing atherosclerosis progression at a dose of 3,600 FU/day, confirming that dose escalation is associated with stronger long-term cardiovascular outcomes [3].

How to Use Nattokinase Effectively

Timing: Take nattokinase on an empty stomach — typically 30–60 minutes before breakfast or 2+ hours after dinner. Food can interfere with absorption and reduce bioavailability.

Dosage for blood pressure and general cardiovascular support: Most clinical trials use 2,000 FU daily (100 mg), taken as a single morning dose [1]. This is the standard dose for general cardiovascular health and modest blood pressure support.

Dosage for plaque reduction (research dose): The largest plaque-regression study used 10,800 FU daily, typically split into morning and evening doses [3]. This higher dose is not typical for over-the-counter formulations but represents the amount used in clinical trials showing meaningful arterial remodeling.

Duration: Give nattokinase at least 8 weeks before assessing blood pressure or general cardiovascular benefits. If plaque reduction is the goal, 12 months of consistent use is supported by clinical evidence.

Consistency: Missing doses reduces efficacy. Nattokinase's effects are cumulative; sporadic use will not produce meaningful benefits.

Interactions: Nattokinase has mild anticoagulant-like activity and should not be combined with prescription blood thinners (warfarin, apixaban, etc.) without medical supervision. Discontinue at least 2 weeks before elective surgery.

BioAbsorb Nattokinase: Dose, Formulation, and Timing

BioAbsorb Nattokinase Enzyme provides 100 mg per capsule (2,000 FU of fibrinolytic activity), matching the clinical dose used in most blood pressure and cardiovascular support trials.

The formulation uses DRcaps delayed-release veggie capsule technology, which protects the enzyme from stomach acid and delivers nattokinase intact to the small intestine for optimal absorption. This is significant: standard enteric-coated capsules use phthalate plasticizers that can accumulate with long-term use. BioAbsorb's formulation is free of phthalates and plasticizers, making it suitable for sustained supplementation.

Each bottle contains 60 capsules (a 60-day supply at the standard 1 capsule daily dose), with the product third-party tested for potency (≥2,000 FU per capsule), heavy metals, and microbial contaminants.

The product is non-GMO, manufactured in a GMP-certified Canadian facility, and free of gluten, nuts, eggs, dairy, fish, shellfish, and animal products — meaningful for anyone with allergen sensitivities or who is vegan.

Dosing: Take 1 capsule once daily on an empty stomach. For comparison to the large plaque-reduction trials (which used 10,800 FU), BioAbsorb provides a dose aligned with the most commonly used clinical protocol for general cardiovascular support and blood pressure management.

Frequently Asked Questions

Q: How fast will I feel nattokinase working?
A: You likely won't "feel" it acutely. Nattokinase doesn't produce the obvious physical sensation that, say, a blood pressure medication might. Early signs include improved energy or better sleep quality, often appearing 2–4 weeks in. Blood pressure changes are measurable with a home monitor by 8 weeks, but subjective sensations vary widely.

Q: Can nattokinase actually dissolve arterial plaque?
A: "Dissolve" may be too strong a word. More accurately, nattokinase supports plaque regression by reducing fibrin content within plaques, improving lipid profiles, and reducing inflammation. Over 12 months at high doses (10,800 FU daily), clinical studies show measurable shrinking of existing plaque burden — but this requires the sustained, high-dose protocol, not standard consumer doses.

Q: Can I take nattokinase if I'm on a blood thinner?
A: Not without medical supervision. Nattokinase has mild anticoagulant-like activity and should not be combined with prescription anticoagulants (warfarin, apixaban, rivaroxaban, etc.) unless a cardiologist or hematologist has approved the combination and is monitoring your blood clotting parameters.

Q: How long should I take nattokinase?
A: For general cardiovascular health, most research suggests ongoing use — 6 months to indefinitely. Nattokinase's benefits appear to persist with consistent use, and cardiovascular health is a lifelong concern. However, before starting long-term supplementation, consult your healthcare provider about your specific cardiovascular risk profile.

Q: Is nattokinase safe for long-term use?
A: Yes. Clinical studies report no notable adverse events from nattokinase supplementation, even in trials lasting 12 months or longer. The most important safety consideration is avoiding concurrent use with prescription blood thinners without medical approval.

Q: When should I stop nattokinase before surgery?
A: Nattokinase should be discontinued at least two weeks prior to any scheduled surgery to minimize perioperative hemorrhage risk. Discuss the timing with your surgeon, as individual protocols may vary.

Conclusion

The answer to "How long does it take for nattokinase to clean your arteries?" is: It depends on your goal, your dose, and your baseline health status.

Immediate effects (hours): Nattokinase activates fibrinolysis within hours of ingestion, supporting your body's natural clot-dissolving system.

Short-term cardiovascular benefits (2–8 weeks): Blood pressure reductions and improved blood flow emerge gradually, with measurable benefits evident by 8 weeks of consistent use.

Long-term arterial remodeling (12 months): High-dose nattokinase (10,800 FU daily) correlates with measurable plaque regression over 12 months — but this requires the higher research dose and consistent supplementation.

Nattokinase is not a quick fix. It's a cumulative, evidence-supported strategy for supporting your cardiovascular system through the enzyme's natural fibrinolytic properties. For most people, 8 weeks is the minimum timeframe to assess whether nattokinase fits into their broader cardiovascular health plan.

If you're interested in exploring nattokinase as part of a comprehensive cardiovascular strategy, BioAbsorb's nattokinase supplement provides the clinically studied 2,000 FU dose in a stable, phthalate-free delayed-release formulation. Start with consistent daily supplementation, monitor your blood pressure or other markers over 8 weeks, and discuss long-term use with your healthcare provider — especially if you have existing cardiovascular disease or are on any medications.

---

Publish Date: July 2026

Last Updated: July 28, 2026

---

Research References

1. Li, X., Long, J., Gao, Q., Pan, M., Wang, J., Yang, F., & Zhang, Y. (2023). Nattokinase supplementation and cardiovascular risk factors: a systematic review and meta-analysis of randomized controlled trials. Journal of Clinical Medicine, 24(8), 234. https://www.imrpress.com/journal/RCM/24/8/10.31083/j.rcm2408234
2. Liu, X., Zeng, X., Mahe, J., et al. (2023). The effect of nattokinase-monascus supplements on dyslipidemia: a four-month randomized, double-blind, placebo-controlled clinical trial. Nutrients, 15(19), 4239. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574353/
3. Chen, H., Chen, J., Zhang, F., Li, Y., Wang, R., Zheng, Q., Zhang, X., Zeng, J., Xu, F., & Lin, Y. (2022). Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: a clinical study with 1,062 participants. Frontiers in Cardiovascular Medicine, 9, 964977. https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.964977/full
4. Kurosawa, Y., Nirengi, S., Homma, T., Esaki, K., Ohta, M., Clark, J. F., et al. (2015). A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles. Scientific Reports, 5, 11601. https://www.nature.com/articles/srep11601
5. Hodis, H. N., Mack, W. J., Meiselman, H. J., Kalra, V., Liebman, H., Hwang-Levine, J., et al. (2021). Nattokinase atherothrombotic prevention study: a randomized controlled trial. Clinical Hemorheology and Microcirculation, 78, 339–353.
6. Jensen, G. S., Lenninger, M. E., Ero, M. P., & Benson, K. F. (2016). Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial. Integrative Blood Pressure Control, 9, 95–104.
7. Kim, J. Y., Gum, S. N., Paik, J. K., Lim, H. H., Kim, K. C., Ogasawara, K., et al. (2008). Effects of nattokinase on blood pressure: a randomized, controlled trial. Hypertension Research, 31, 1583–1588.
8. Research Progress of Nattokinase in Reducing Blood Lipid. PubMed Central, PMC12157000. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12157000/
9. BioAbsorb Nutraceuticals Official Website. https://www.bioabsorbnutraceuticals.com
10. BioAbsorb Nattokinase Enzyme Product Page. https://www.bioabsorbnutraceuticals.com/products/nattokinase-supplement-non-gmo-natto-extract-enzyme-100-mg-2000-fus-60-veggie-caps-60-day-supply

---

Author Bio

David Kimbell is a certified health writer with 8+ years of experience in evidence-based nutritional science and clinical research synthesis. His work bridges peer-reviewed evidence and accessible consumer health content, with a focus on cardiovascular health, supplement science, and functional medicine applications. David has contributed to publications covering naturopath education, integrative medicine protocols, and supplement efficacy research.

---

Medical Disclaimer

The information in this article is for educational purposes only and should not be construed as medical advice. Nattokinase is a dietary supplement, not a medication, and has not been evaluated by the FDA for diagnosis, treatment, cure, or prevention of any disease.

This article does not replace professional medical advice. If you have existing cardiovascular disease, take prescription medications (especially anticoagulants or antiplatelets), or have a personal or family history of clotting disorders, consult your healthcare provider before beginning nattokinase supplementation. Do not use nattokinase as a replacement for prescribed cardiovascular medications or lifestyle interventions.

Nattokinase may interact with anticoagulant medications (warfarin, apixaban, etc.) and should not be combined with these drugs without explicit medical supervision and blood clotting parameter monitoring. Discontinue nattokinase at least 2 weeks before elective surgery.

If you experience unusual bleeding, bruising, or adverse effects during nattokinase supplementation, discontinue use and seek immediate medical attention.

---

FDA and Health Canada Statement

Nattokinase is classified as a dietary supplement in the United States and Canada. Dietary supplements are not subject to the same regulatory review as pharmaceutical drugs and are not intended to diagnose, treat, cure, or prevent disease.

The FDA has not evaluated the safety or efficacy of nattokinase as a supplement for cardiovascular conditions. Health Canada similarly regulates nattokinase as a supplement, not a therapeutic agent. Any health claims made regarding nattokinase in this article reflect research published in peer-reviewed journals and do not imply regulatory approval or endorsement by the FDA or Health Canada.

Consumers are encouraged to review the latest regulatory guidance and clinical evidence with their healthcare providers before purchasing or using nattokinase supplements.